CD20+, B-cell Lymphomas
1 clinical trials · Condition
◉ Watch CD20+, B-cell Lymphomas
| Record | Firm | Date |
|---|---|---|
| Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma (NCT01665768) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-01 |
Track CD20+, B-cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.